-
The role of perioperative chemoimmunotherapy in resectable non-small cell lung cancer: insights from the NADIM trial
de Koning, A., Houda, I., Ulas, E. B. & Bahce, I., 31 Jul 2025, In: Translational lung cancer research. 14, 7, p. 2383-2386Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: The INCREASE study
Bahce, I., Dickhoff, C., Schneiders, F. L., Veltman, J., Heineman, D. J., Hashemi, S. M. S., Vrijmoet, A., Houda, I., Ulas, E. B., Bakker, J., van de Ven, P., Bouwhuis, N., Meijboom, L. J., Oprea-Lager, D. E., van Maldegem, F., Fransen, M. F., de Gruijl, T. D., Radonic, T. & Senan, S., 30 Sept 2024, In: Journal for Immunotherapy of Cancer. 12, 9, e009799.Research output: Contribution to journal › Article* › Academic › peer-review
-
First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET
Pouw, J. E. E., Hashemi, S. M. S., Huisman, M. C., Wijngaarden, J. E., Slebe, M., Oprea-Lager, D. E., Zwezerijnen, G. J. C., Vugts, D., Ulas, E. B., de Gruijl, T. D., Radonic, T., Senan, S., Menke-van der Houven van Oordt, C. W. & Bahce, I., 1 Feb 2024, In: Journal for immunotherapy of cancer. 12, 2, e007659.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
